Financial report interval: 2025.12.31 - 2026.03.31
Preview: Genmab A/S(GMAB) predict that the Revenue is 872.8 M (+27.14%), Beat estimate;the EBIT is 175.34 M (-2.86%), Beat estimate;the EPS is 0.0127 (-71.23%), Miss estimate.